Detalhe da pesquisa
1.
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
JAMA
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683596
2.
Oncologists' responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study.
Support Care Cancer
; 31(8): 450, 2023 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421495
3.
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
Future Oncol
; 17(34): 4665-4676, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636255
4.
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment.
Pharmacogenet Genomics
; 27(11): 402-409, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28877533
5.
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.
Oncologist
; 21(7): 795-803, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226358
6.
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
Br J Clin Pharmacol
; 80(5): 1122-30, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907378
7.
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients with Cancer.
medRxiv
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38106014
8.
Tamoxifen and CYP2D6: a contradiction of data.
Oncologist
; 17(5): 620-30, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531359
9.
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760).
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34429332
10.
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
J Clin Oncol
; 39(35): 3938-3958, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324366
11.
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
JCO Precis Oncol
; 52021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476329
12.
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019.
Clin Cancer Res
; 21(12): 2771-9, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25779948
13.
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.
Clin Cancer Res
; 21(12): 2722-9, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25779953
14.
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.
J Clin Oncol
; 29(24): 3232-9, 2011 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768473
15.
Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.
Clin Breast Cancer
; 10(6): 465-70, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21147690
16.
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
Pharmacogenomics
; 11(1): 13-21, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20017668
17.
What is triple-negative breast cancer?
Eur J Cancer
; 44(18): 2799-805, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19008097